Drug Trial Radar · NCT01902290
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Adults With Inadequately Controlled Asthma With High Bronchodilator Reversibility
Last checked: Nov 20, 2026Latest source record: Sep 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
421
Actual
Start
May 22, 2013
Primary completion
May 15, 2015
Study completion May 15, 2015
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- Collaborators
- Kyowa Kirin Co., Ltd.; AstraZeneca
- First posted
- Jul 18, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if brodalumab (AMG 827) is safe and effective compared to placebo as measured by change in Asthma Control Questionnaire (ACQ) composite scores.
Conditions
- Asthma
Interventions
PlaceboBiological
Placebo administered subcutaneously
BrodalumabBiological
Brodalumab administered subcutaneously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Asthma Control Questionnaire (ACQ) Composite Score at Week 24Time frame: Baseline and week 24
Locations
161 sites in 15 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Glendale, Arizona
Research Site
Phoenix, Arizona
Research Site
Scottsdale, Arizona
Research Site
Little Rock, Arkansas
Research Site
Bakersfield, California
Research Site
Encinitas, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Newport Beach, California
Research Site
North Hollywood, California
Research Site
Orange, California
Research Site
Palmdale, California
Research Site
Rolling Hills Estates, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
San Jose, California
Research Site
Santa Monica, California
Research Site
Stockton, California
Research Site
Colorado Springs, Colorado
Research Site
Waterbury, Connecticut
Research Site
Aventura, Florida
Research Site
Hialeah, Florida
Research Site
Jacksonville, Florida
Research Site
Lynn Haven, Florida
Research Site
Miami, Florida
Research Site
Orlando, Florida
Research Site
Port Orange, Florida
Research Site
Tallahassee, Florida
Research Site
Decatur, Georgia
Research Site
Lawrenceville, Georgia
Research Site
Eagle, Idaho
Research Site
Chicago, Illinois
Research Site
Chicago, Illinois
Research Site
Normal, Illinois
Research Site
Peoria, Illinois
Research Site
Iowa City, Iowa
Research Site
Paducah, Kentucky
Research Site
Baltimore, Maryland
Research Site
Baltimore, Maryland
Showing 40 of 161 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.